Diversified Healthcare Trust (DHC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Q3 2024 results reflect a diversified healthcare real estate portfolio valued at $7.2 billion, with 368 properties in 36 states and D.C., including 8.2 million sq. ft. of medical office/life science space and over 27,000 senior living units.
SHOP segment NOI grew 32.6% year-over-year to $27.4 million, with occupancy up to 79.4% and average monthly rates up 5.4%; however, sequential progress was limited by higher costs and slow occupancy gains.
Net loss for Q3 2024 was $98.7 million, driven by higher impairment charges and increased expenses.
Strategic initiatives include a $348.1 million property disposition program, with proceeds aimed at reducing leverage and partially redeeming senior secured notes due 2026.
Managed by The RMR Group, overseeing nearly $41 billion in assets as of September 30, 2024.
Financial highlights
Q3 2024 total revenues were $373.6 million, up 4.8% year-over-year; normalized FFO was $4.0 million ($0.02 per share), and adjusted EBITDAre increased 13.6% to $66.8 million.
Net loss per share was $(0.41) for Q3 2024; same property cash basis NOI was $65.8 million, up 16.1% year-over-year but down 1.5% sequentially.
SHOP segment Q3 2024 revenues were $312.0 million (up 6.4% year-over-year), with NOI margin up 240 bps year-over-year.
Medical Office/Life Science Portfolio Q3 2024 NOI was $27.8 million (down 4.9%), with occupancy at 80.8%.
Cash and cash equivalents at September 30, 2024, were $256.5 million.
Outlook and guidance
Full-year SHOP NOI guidance lowered to $102-$107 million due to Q3 underperformance and hurricane-related costs; year-end SHOP occupancy expected just below 80%.
Full-year CapEx guidance reduced to $180-$190 million, with $118 million spent through September; SHOP CapEx expected at $130-$140 million.
Management expects continued improvement in SHOP segment performance, supported by favorable supply-demand dynamics and moderating cost increases.
Proceeds from pending property sales to be used for partial redemption of senior secured notes due 2026.
Sufficient liquidity is expected to meet obligations and fund operations for at least the next 12 months.
Latest events from Diversified Healthcare Trust
- Q2 2026 saw SHOP-driven NOI growth, margin gains, and reaffirmed guidance.DHC
Q2 2026 - Operational improvements and internal growth drive optimism for further upside.DHC
Nareit REITweek: 2026 Investor Conference - Raised 2026 guidance and strong SHOP growth drive sector-leading returns and balance sheet gains.DHC
Investor presentation - Record shareholder returns and robust SHOP growth driven by strategic asset management.DHC
Investor presentation - Q1 2026 net loss was $43.3M as SHOP NOI rose and 2026 guidance was reaffirmed.DHC
Q1 2026 - Updated sustainability metrics and climate risk strategies underscore ongoing ESG leadership.DHC
Proxy filing - Proxy covers trustee elections, say-on-pay, auditor ratification, and robust ESG and governance practices.DHC
Proxy filing - Trustee elections, executive pay, and auditor ratification headline the June 2026 meeting.DHC
Proxy filing - Record NOI growth, margin expansion, and debt reduction drive strong shareholder returns.DHC
Q4 2025